Pharmacists in Phenix City, AL Accepting Medicare
46 Pharmacists found. Showing 41 - 46
 Dr. John Barson Moulton Ii, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 343 Lee Road 593, Phenix City, AL 36870 Phone: 706-442-1377 |
 Rebecca Ashley Moulton, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2515 Crawford Rd, Phenix City, AL 36867 Phone: 334-297-2284 |
Zakiya Harris, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2515 Crawford Rd, Phenix City, AL 36867 Phone: 334-297-3722 |
Steven Michael Tillery Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5408 Summerville Rd, Phenix City, AL 36867 Phone: 334-291-8533 Fax: 334-291-8532 |
Dr. Eric D Long, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5301 Summerville Rd, Phenix City, AL 36867 Phone: 334-297-3061 Fax: 334-297-0193 |
Minyoung Kim, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2515 Crawford Rd, Phenix City, AL 36867 Phone: 334-297-3722 |
News Archive
Study pioneers phenotyping of human metabolome
The old excuse, "I am only overweight because of my genes," is suddenly gaining credibility as researchers uncover ever more evidence that the way our bodies digest and process nutrients in the food we eat is different for every person. The budding discipline of metabolomics strives to investigate these differences in a scientific manner.
Researchers evaluate use of pharmacy-based naloxone education and distribution to fight opioid overdoses
In response to the growing opioid crisis, several states, including Massachusetts and Rhode Island, have granted pharmacists the authority to provide naloxone rescue kits without a prescription to at-risk patients. This model of pharmacy-based naloxone (PBN) education and distribution is one of the public health strategies currently being evaluated at hundreds of pharmacies in both states to determine the impact on opioid overdose death rates.
New NIH projects to target Fragile X syndrome, nicotine addiction and AMD
The National Institutes of Health has launched three innovative projects that will focus on development of therapeutics for Fragile X syndrome, nicotine addiction, and age-related macular degeneration. These projects are funded through the NIH Blueprint Neurotherapeutics Network which provides access to a variety of drug development resources.
Over 125,000 NYU Langone patients now use new biometric identification system
Launched just nine months ago, more than 125,000 patients at NYU Langone Medical Center are now using PatientSecure, a cutting-edge biometric identification system.
Johns Hopkins researchers uncover role of neurotransmitter in the spread of aggressive cancers
Using human cancer cells, tumor and blood samples from cancer patients, researchers at Johns Hopkins Medicine have uncovered the role of a neurotransmitter in the spread of aggressive cancers. Neurotransmitters are chemical "messengers" that transmit impulses from neurons to other target cells.
› Verified 4 days ago
Pharmacists
Counselors
Dentists
Clinical Social Workers
Psychologists
Occupational Therapists